Publication:
Combined immunodeficiency due to purine nucleoside phosphorylase deficiency: Outcome of three patients

Placeholder

Organizational Units

Authors

Torun, Başak
Bilgin, Ahmet
Orhan, Diclehan
Göçmen, Rahşan
Kılıç, Şebnem Sara
Kuşkonmaz, Barış
Çetinkaya, Duygu
Tezcan, İlhan
Çağdaş, Deniz

Advisor

Language

Publisher:

Elsevier

Journal Title

Journal ISSN

Volume Title

Abstract

Purine nucleoside phosphorylase (PNP) is a key enzyme in the purine salvage pathway. PNP deficiency, caused by the autosomal recessive mutations in the PNP gene, can lead to severe combined immunodeficiency (SCID). PNP deficiency patients typically have profound T-cell deficiency with variable B and NK cell functions. They present clinically with recurrent infections, failure to thrive, various neurological disorders, malignancies, and autoimmune diseases. Hematopoietic stem cell transplantation (HSCT) is the only available cure for patients with PNP deficiency. We present three patients, two of whom were successfully treated with HSCT. One patient died prior to HSCT due to EBV-associated lymphoma. Over the course of post-HSCT, there was no further aggravation of the patients' neurological symptoms. Although both of the patients still had mild developmental delay, new developmental milestones were achieved.

Description

Source:

Keywords:

Keywords

Toxic metabolite, Triphosphate, Dysfunction, Mutations, Purine nucleoside phosphorylase, Low uric acid, Severe combined immunodeficiency, T cell deficiency, Hematopoietic stem cell transplantation, Genetics & heredity

Citation

Endorsement

Review

Supplemented By

Referenced By

0

Views

0

Downloads

View PlumX Details